Rapid Infusion Daratumumab Is Safe in Patients with AL Amyloidosis

被引：1
|
作者：
Rosko, Nathaniel [1 ]
Mo, Hanjie [1 ]
Rudoni, Joslyn [1 ]
Siebenaller, Caitlin [1 ]
Lee, Sarah S. [2 ]
Chakraborty, Rajshekar [2 ]
Faiman, Beth M. [2 ]
Khouri, Jack [2 ]
Garcia, Alex V. Mejia [2 ]
Samaras, Christy J. [2 ]
Anwer, Faiz [2 ]
Valent, Jason [2 ]
机构：
[1] Cleveland Clin, Dept Pharm, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-124775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1838
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab
    Szalat, Raphael E.
    Gustine, Joshua
    Sloan, J. Mark
    Edwards, Camille, V
    Sanchorawala, Vaishali
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (01) : 79 - 89
  • [12] Treatment with Daratumumab in Patients with Multiple Myeloma Associated AL Amyloidosis
    Milani, Paolo
    Fazio, Francesca
    Basset, Marco
    Berno, Tamara
    Larocca, Alessandra
    Foli, Andrea
    Riva, Marcello
    Oliva, Stefania
    Ripepi, Jessica
    Nuvolone, Mario
    Petrucci, Maria Teresa
    Merlini, Giampaolo
    Palladini, Giovanni
    BLOOD, 2019, 134
  • [13] Daratumumab-based therapies in patients with AL amyloidosis.
    Abeykoon, Jithma P.
    Zanwar, Saurabh
    Kumar, Shaji
    Dispenzieri, Angela
    Rajkumar, S. Vincent
    Lacy, Martha
    Dingli, David
    Leung, Nelson
    Muchtar, Eli
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Buadi, Francis
    Kyle, Robert A.
    Gertz, Morie A.
    Kapoor, Prashant
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [14] Impact of the Addition of Daratumumab to the Frontline Treatment of Patients With Al Amyloidosis
    Alejo, Elena
    Puertas, Borja
    Rey-Bua, Beatriz
    Agullo, Cristina
    Eiros-Bachiller, Rocio
    Gallego-Delgado, Maria
    Heras, Manuel
    Santos-Briz, Angel
    Perez-Garcia, Maria Luisa
    Garcia-Sanz, Ramon
    Puig, Noemi
    Mateos Manteca, Maria-Victoria
    Gonzalez-Calle, Veronica
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S202 - S202
  • [15] Role of Daratumumab in Cardiac AL Amyloidosis
    Gertz, Morie A.
    JACC: CARDIOONCOLOGY, 2022, 4 (04): : 488 - 490
  • [16] Use of daratumumab in patients with amyloidosis
    Anzai, Adriano
    Utino, Armelin
    Katayama, Haroldo
    Spir, Ighor A. Z.
    Lemos, Marcio A.
    Anhesini, Mauricio
    Tiezzi, Oswaldo S.
    Spir, Patricia R. N.
    Otani, Pericles
    Bernardo, Wanderley M.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (11): : 1468 - 1471
  • [17] Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab
    Bellofiore, Claudia
    Palladini, Giovanni
    Milani, Paolo
    CURRENT ONCOLOGY REPORTS, 2024, 26 (09) : 1097 - 1103
  • [18] Progress in research: Daratumumab improves treatment outcomes of patients with AL amyloidosis
    Hassan, Hamza
    Anwer, Faiz
    Javaid, Anum
    Hashmi, Hamza
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 165
  • [19] Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment
    Gounot, Romain
    Le Bras, Fabien
    Dupuis, Jehan
    Oghina, Silvia
    Bodez, Diane
    Roulin, Louise
    Maarek, Alizee
    Ladaique, Amandine
    Beldi-Ferchiou, Asma
    Poullot, Elsa
    Molinier-Frenkel, Valerie
    Haioun, Corinne
    Damy, Thibaud
    Belhadj, Karim
    Lemonnier, Francois
    LEUKEMIA & LYMPHOMA, 2021, 62 (04) : 979 - 983
  • [20] Quantitation of daratumumab among AL amyloidosis patients by M-quant measurement
    Dispenzieri, Angela
    Coker, Jon
    Kohlhagen, Mindy
    Kourelis, Taxiarchis
    Willrich, Mia
    Dasari, Surendra
    Buadi, Francis K.
    Cook, Joselle M.
    Dingli, David
    Fonder, Amie
    Gertz, Morie
    Gonsalves, Wilson
    Hayman, Suzanne
    Hobbs, Miriam
    Hwa, Lisa
    Kapoor, Prashant
    Muchtar, Eli
    Rogers, Michelle
    Warsame, Rahma
    Rajkumar, Vincent
    Kumar, Shaji
    Murray, David
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S168 - S169
12345